Inaktiver Wert

Andere Sprachen CombiMatrix Corp

Aktien

US20009T5011

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

CombiMatrix Corporation Stockholders Approve Merger Agreement With Invitae Corporation	10.11.17
CombiMatrix Corporation Reports Third Quarter 2017 Financial and Operating Results	06.11.17
CombiMatrix Corporation Reminds Shareholders to Vote "FOR" the Merger With Invitae Corporation	02.11.17
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend CombiMatrix Corporation Shareholders Vote "FOR" the Proposed Merger with Invitae Corporation	01.11.17
CombiMatrix to Present New Data from a Large-Scale Analysis of Genomic Abnormalities Impacting Multiple Stages of Human Growth and Development Starting from Conception through Childhood at the American Society of Human Genetics Annual Meeting	20.10.17
CombiMatrix Sets Record Date and Special Stockholders Meeting Date Regarding Proposed Merger with Invitae	25.09.17
CombiMatrix Corporation Reports Second Quarter 2017 Financial and Operating Results	03.08.17
CombiMatrix Enters Into Merger Agreement with Invitae Corporation to be Acquired for $33 Million in Invitae Common Stock	31.07.17
CombiMatrix to Present at Upcoming Investor Conferences	22.05.17
CombiMatrix Corporation Reports First Quarter 2017 Financial and Operating Results	04.05.17
CombiMatrix Corporation to Release 2017 First Quarter Financial Results on May 4, 2017	27.04.17
CombiMatrix Appoints Molecular Diagnostics Veteran Dirk van den Boom, Ph.D. to its Board of Directors	01.03.17
CombiMatrix Corporation Reports 2016 Fourth Quarter and Full Year Financial and Operating Results	22.02.17
CombiMatrix Corporation to Release 2016 Fourth Quarter and Full Year Financial Results on February 22, 2017	15.02.17
CombiMatrix to Present at 2nd Annual Disruptive Growth & Healthcare Conference	08.02.17
CombiMatrix Appoints Preeminent Pediatric Neurologist Dr. James W. Wheless to its Scientific Advisory Board	02.02.17
CombiMatrix to Present Large-Scale Study Indicating the Severity of Genomic Abnormalities Decreases from Conception to Childhood at the 2nd Congress on Recurrent Pregnancy Loss	20.01.17
CombiMatrix : Pre-Implantation Genetic Screening by Next Generation Sequencing Granted Conditional Approval from New York State Department of Health	29.11.16
CombiMatrix’s Pre-Implantation Genetic Screening by Next Generation Sequencing Granted Conditional Approval from New York State Department of Health	29.11.16
CombiMatrix Corporation Reports Third Quarter 2016 Financial and Operating Results	02.11.16

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen CombiMatrix Corp

Aktien

US20009T5011

Andere Sprachen

Filter